LACEY SCHWANEBECK: Open Payments
NPI 1124793005 · WISCONSIN RAPIDS, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,627 in 97 payments from 14 companies in 2025. Trend: 2023 $1,379 · 2024 $1,346 · 2025 $1,627
Food & beverage: $1,617Education: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $313 |
| UCB, Inc. | 21 | $307 |
| Regeneron Healthcare Solutions, Inc. | 7 | $202 |
| Lilly USA, LLC | 12 | $194 |
| GENZYME CORPORATION | 7 | $167 |
| E.R. Squibb & Sons, L.L.C. | 5 | $95 |
| Amgen Inc. | 4 | $82 |
| Novartis Pharmaceuticals Corporation | 4 | $79 |
| LEO Pharma Inc. | 3 | $59 |
| Janssen Biotech, Inc. | 2 | $44 |
Products named: DUPIXENT, Bimzelx, SKYRIZI, TALTZ, RINVOQ, Sotyktu, OTEZLA, COSENTYX.
Industry payments across WI — which companies pay providers there.
